Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Antisense Therapeutics Ltd

+ Add to Watchlist

AWY:GR

0.057 EUR 0.012 26.67%

As of 02:08:03 ET on 04/01/2015.

Company Profile for Antisense Therapeutics Ltd (AWY)

Antisense Therapeutics Limited develops and markets drugs for treatment of diseases like psoriasis, multiple sclerosis, autoimmune, cancer, metabolic and cardiovascular. The drugs are based on small synthetic genetic molecules. The Company has collaboration with Isis Pharmaceuticals in the United States, which provides the Company access to drug development technology.

Contact Information

Antisense Therapeutics Ltd

Level 1
10 Wallace Avenue
Toorak, VIC 3142
Australia
Phone: 61-3-9827-8999
Fax: 61-3-9827-1166

Key Executives for Antisense Therapeutics Ltd (AWY)

Mark P DiamondCEO/Managing DirectorPhillip HainsCFO/Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil